Jasdeep Singh

Jasdeep Singh is the Chief Executive Officer and co-Founder of SingleTimeMicroneedles (STM), a cutting-edge biotechnology company in Connecticut.

STM's painless microneedle patch is the only one in development that can deliver a drug/peptide/vaccine in a single dose, over time, or at pre-engineered times. STM is currently in pre-commercial trials and will be engaged in full-scale manufacturing in 2027.

Jasdeep's strength lies in being able to organize and coordinate cross-functional teams at all stages of technical and operational development. Bringing ideas from bench-scale to a commercially viable product and company is a challenging path, but one that Jasdeep loves.

Biotechnology start-ups are our future's best chance to truly innovate and positively change peoples health and lives.

Jasdeep Singh earned his MBA from the University of Connecticut and has extensive experience in organizational leadership, project and change management, and technical leadership. Being a technical and business leader within the company has allowed him to expand into marketing, client relations, talent development, and data analysis.

Jasdeep Singh completed his Bachelor of Science in Secondary Life Sciences and Master of Arts in Education also from the University of Connecticut.

Jasdeep Singh is also an accomplished presenter and pitch developer, winning SXSW in 2024 and leading panels on how animal and human health intertwine in biotechnology and community health.